Literature DB >> 29729005

Can the positive association of osteocalcin with testosterone be unmasked when the preeminent hypothalamic-pituitary regulation of testosterone production is impaired? The model of spinal cord injury.

A Barbonetti1, S D'Andrea2, J Samavat3, A Martorella2, G Felzani4, S Francavilla2, M Luconi3, F Francavilla2.   

Abstract

PURPOSE: Osteocalcin (OCN), released from the bone matrix during the resorption phase, in its undercarboxylated form, stimulates testosterone (T) biosynthesis in mouse and a loss-of-function mutation of its receptor was associated with hypergonadotropic hypogonadism in humans. Nevertheless, when population-based studies have explored the OCN-T association, conflicting results have been reported. Hypothesizing that the evidence of a positive association between OCN and T could have been hindered by the preeminent role of a well-functioning hypothalamus-pituitary axis in promoting T biosynthesis, we explored this association in men with chronic spinal cord injury (SCI), exhibiting high prevalence of non-hypergonadotropic androgen deficiency.
METHODS: Fifty-five consecutive men with chronic SCI underwent clinical/biochemical evaluations, including measurements of total T (TT), OCN and 25(OH)D levels. Free T (FT) levels were calculated by the Vermeulen formula. Comorbidity was scored by Charlson comorbidity index (CCI).
RESULTS: A biochemical androgen deficiency (TT < 300 ng/dL) was observed in 15 patients (27.3%). TT was positively correlated with OCN, 25(OH)D and leisure time physical activity and negatively correlated with age, BMI and CCI. OCN was also positively correlated with calculated FT and negatively correlated with BMI and HOMA-IR. At the multiple linear regression analyses, a positive association of OCN with TT and calculated FT persisted after adjustment for confounders.
CONCLUSIONS: The positive association here found between OCN and T levels in men with chronic SCI reinforces the notion that a bone-testis axis is also functioning in humans and suggests that it can be unmasked when the preeminent hypothalamic-pituitary regulation of T production is impaired.

Entities:  

Keywords:  Androgen deficiency; Bone metabolism; Hypogonadism; Insulin; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 29729005     DOI: 10.1007/s40618-018-0897-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  45 in total

1.  Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus.

Authors:  I Kanazawa; K Tanaka; N Ogawa; M Yamauchi; T Yamaguchi; T Sugimoto
Journal:  Osteoporos Int       Date:  2012-06-06       Impact factor: 4.507

2.  Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men.

Authors:  Ilpo T Huhtaniemi; Abdelouahid Tajar; David M Lee; Terence W O'Neill; Joseph D Finn; György Bartfai; Steven Boonen; Felipe F Casanueva; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Fernand Labrie; Michael E J Lean; Neil Pendleton; Margus Punab; Alan J Silman; Dirk Vanderschueren; Gianni Forti; Frederick C W Wu
Journal:  Eur J Endocrinol       Date:  2012-03-15       Impact factor: 6.664

3.  The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.

Authors:  Hye-Jung Kim; Hyung Suk Koo; Young-Sang Kim; Moon Jong Kim; Kwang-Min Kim; Nam-Seok Joo; Ji-Hee Haam
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

4.  Role of metabolic factors in the association between osteocalcin and testosterone in Chinese men.

Authors:  Ming Liao; Xuefeng Guo; Xiaoxiang Yu; Guijian Pang; Shijun Zhang; Jianling Li; Aihua Tan; Yong Gao; Xiaobo Yang; Haiying Zhang; Xue Qin; Linjian Mo; Zheng Lu; Chunlei Wu; Zengnan Mo
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

5.  Age-related prevalence of low testosterone in men with spinal cord injury.

Authors:  William A Bauman; Michael F La Fountaine; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

6.  Healthy body mass index values often underestimate body fat in men with spinal cord injury.

Authors:  Lynnette M Jones; Michael Legge; Ailsa Goulding
Journal:  Arch Phys Med Rehabil       Date:  2003-07       Impact factor: 3.966

7.  Low vitamin D levels are independent predictors of 1-year worsening in physical function in people with chronic spinal cord injury: a longitudinal study.

Authors:  Arcangelo Barbonetti; Settimio D'Andrea; Alessio Martorella; Giorgio Felzani; Sandro Francavilla; Felice Francavilla
Journal:  Spinal Cord       Date:  2018-01-16       Impact factor: 2.772

Review 8.  Osteocalcin: skeletal and extra-skeletal effects.

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

9.  Longitudinal study of bone loss in chronic spinal cord injury patients.

Authors:  Inanc Karapolat; Hale Uzumcugil Karapolat; Yesim Kirazli; Kazim Capaci; Yesim Akkoc; Kamil Kumanlioglu
Journal:  J Phys Ther Sci       Date:  2015-05-26

10.  Endocrine actions of osteocalcin.

Authors:  Aurora Patti; Luigi Gennari; Daniela Merlotti; Francesco Dotta; Ranuccio Nuti
Journal:  Int J Endocrinol       Date:  2013-04-30       Impact factor: 3.257

View more
  3 in total

1.  Relationship of Vitamin D status with testosterone levels: a systematic review and meta-analysis.

Authors:  S D'Andrea; A Martorella; F Coccia; C Castellini; E Minaldi; M Totaro; A Parisi; F Francavilla; S Francavilla; A Barbonetti
Journal:  Endocrine       Date:  2020-09-03       Impact factor: 3.633

2.  Factors associated with osteocalcin in men with spinal cord injury: findings from the FRASCI study.

Authors:  Ricardo A Battaglino; Nguyen Nguyen; Megan Summers; Leslie R Morse
Journal:  Spinal Cord       Date:  2019-07-12       Impact factor: 2.772

3.  Quercetin Attenuates Osteoporosis in Orchiectomy Mice by Regulating Glucose and Lipid Metabolism via the GPRC6A/AMPK/mTOR Signaling Pathway.

Authors:  Jie Sun; Yalan Pan; Xiaofeng Li; Lining Wang; Mengmin Liu; Pengcheng Tu; Chengjie Wu; Jirimutu Xiao; Qiuge Han; Weiwei Da; Yong Ma; Yang Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.